Calamos Wealth Management’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
Other funds holding ELV
Calamos Wealth Management's ELV Position: Q1 2022 in Review
Calamos Wealth Management sold out of Elevance Health (ELV) in Q1 2022, closing a stake of 1,447 shares — an estimated $671K sold.
Calamos Wealth Management first reported a position in ELV in Q1 2015 and held it in 17 quarters. The position peaked at $2.13M in Q2 2015. 1,418 funds tracked by Wall St. Rank hold ELV as of Q1 2022.
- Calamos Wealth Management reported no remaining Elevance Health position as of Q1 2022 after selling out during the quarter.
- Calamos Wealth Management sold 1,447 Elevance Health shares in Q1 2022, an estimated $671K.
- Calamos Wealth Management first reported a position in Elevance Health in Q1 2015 and held it in 17 quarters.
- Calamos Wealth Management's Elevance Health position peaked at $2.13M in Q2 2015.
- 1,418 funds tracked by Wall St. Rank held Elevance Health as of Q1 2022.
Based on Calamos Wealth Management's 13F filing for Q1 2022, filed 3 May 2022.